Sarepta Therapeutics (SRPT) PT Lowered to $200 at RBC Capital
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.18 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $200.00 (from $201.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Ollie's Bargain Outlet (OLLI) PT Lowered to $113 at Piper Sandler, 'Favorable Risk/Reward for 2H '
- Iress Ltd. (IRE:AU) PT Lowered to AUD9.09 at Canaccord
- Audinate Group Ltd (AD8:AU) PT Lowered to AUD5.50 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
